FDA MedWatch -Balloon angioplasty devices to treat autonomic dysfunction: FDA Safety Communication – FDA concern over experimental procedures

MedWatch – The FDA Safety Information and Adverse Event Reporting Program   Balloon angioplasty devices to treat autonomic dysfunction: FDA Safety Communication – FDA concern over experimental procedures AUDIENCE: Neurology, Surgery, Health Professional, Patient ISSUE: FDA is alerting the public…

CDER New March 8, 2017

What’s New on the FDA Drugs Site March 7, 2017 Drug Quality: Postmarket Sampling and Testing Results for Drugs (FY 2015) (PDF – 93.24 KB) Drug Quality: Postmarket Sampling and Testing Results for APIs (FY 2015) (PDF – 73.20 KB) Drug Quality:…